The global cardiovascular devices market was valued at USD 74.58 billion in 2025 and is anticipated to reach USD 157.32 billion by 2035, expanding at a CAGR of 7.70% during the forecast period from 2026 to 2035.
The Request of this Sample Report Here: – https://www.astuteanalytica.com/request-sample/cardiovascular-devices-market
The market is undergoing a significant transformation as healthcare providers increasingly adopt minimally invasive cardiovascular procedures, advanced diagnostic technologies, and AI-enabled monitoring systems. Demand is being fueled by the growing prevalence of cardiovascular diseases, aging populations, and continuous innovation in electrophysiology, structural heart therapies, and remote patient monitoring. Industry leaders are shifting their strategic focus from conventional cardiac rhythm management toward next-generation solutions such as Pulsed Field Ablation (PFA) and transcatheter mitral and tricuspid valve interventions, enabling safer procedures and improved patient outcomes.
Key Findings
- By Device Type, Therapeutics & Surgical Devices accounted for 77.5% of total market revenue in 2025.
- By Application, Coronary Artery Disease remained the leading application segment globally.
- By End User, Hospitals continued to represent the largest customer segment due to increasing procedural volumes and advanced infrastructure.
- By Region, North America dominated the global market with a 45.68% revenue share in 2025, supported by rapid technology adoption and favorable reimbursement policies.
Competitive Landscape Strengthened by Innovation
Leading manufacturers continue to report robust financial performance driven by expanding portfolios and innovative cardiovascular technologies.
- Medtronic maintained its leadership position by recording approximately USD 3.44 billion in cardiovascular revenue during Q2 FY2026, supported by increasing adoption of its Sphere-9 PFA and Evolut FX platforms.
- Boston Scientific delivered exceptional growth, reporting more than 22% year-over-year revenue expansion in 2025, largely driven by its Farapulse Pulsed Field Ablation platform and strong electrophysiology demand.
- Abbott achieved double-digit growth across its medical devices business, supported by expanding electrophysiology and structural heart product sales.
- Edwards Lifesciences continued to strengthen its leadership in structural heart therapies with sustained growth in transcatheter valve technologies.
Pulsed Field Ablation Reshaping Electrophysiology
Electrophysiology remains one of the fastest-growing segments within the cardiovascular devices market. Pulsed Field Ablation has emerged as a disruptive technology by offering highly selective cardiac tissue ablation while minimizing damage to surrounding structures.
Boston Scientific has established an early competitive advantage through widespread adoption of its Farapulse technology, while Johnson & Johnson continues expanding its electrophysiology portfolio through the Varipulse platform integrated with advanced cardiac mapping systems. Abbott is also strengthening its competitive position with innovative PFA technologies gaining traction across European healthcare markets.
Structural Heart Therapies Continue to Expand
Although coronary stents and angioplasty balloons remain high-volume products, structural heart interventions are generating stronger revenue growth.
Transcatheter Aortic Valve Replacement (TAVR) continues to witness healthy adoption worldwide, while Transcatheter Mitral and Tricuspid Therapies (TMTT) are emerging as major growth opportunities. Recent regulatory approvals for advanced valve repair systems across Asia and North America further support long-term market expansion as physicians increasingly favor minimally invasive treatment approaches.
AI and Digital Health Accelerating Market Innovation
Artificial intelligence is becoming an integral component of cardiovascular care by enhancing diagnostics, imaging accuracy, workflow automation, and remote patient management.
Emerging companies are developing innovative wearable monitoring solutions, advanced mapping technologies, and precision diagnostic platforms that complement traditional cardiovascular devices. Increased venture funding, accelerator programs, and strategic collaborations continue to expand the innovation pipeline, creating attractive acquisition opportunities for established medical device companies.
Strategic Acquisitions Strengthen Competitive Positioning
Merger and acquisition activity remains intense as global manufacturers seek access to breakthrough technologies.
Recent acquisitions targeting intravascular lithotripsy, coronary imaging, AI-enabled diagnostics, and heart failure therapies demonstrate the industry’s commitment to expanding next-generation cardiovascular treatment portfolios. These strategic investments enable companies to accelerate commercialization while strengthening their competitive positions across high-growth therapeutic categories.
Emerging Markets Offer Long-Term Growth Potential
Developing economies continue to present significant expansion opportunities despite regional pricing pressures.
China remains a major volume market, although centralized procurement policies continue to influence pricing dynamics. In contrast, India, Brazil, Southeast Asia, and other emerging economies are delivering stronger value-based growth as healthcare infrastructure improves and demand for advanced cardiovascular procedures rises. Japan continues to represent a stable premium market characterized by early adoption of innovative structural heart technologies.
𝐅𝐨𝐫 𝐦𝐨𝐫𝐞 𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 Cardiovascular Devices Market 𝐚𝐧𝐝 𝐝𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐢𝐧𝐭𝐨 𝐟𝐮𝐭𝐮𝐫𝐞 𝐭𝐫𝐞𝐧𝐝𝐬, 𝐩𝐥𝐞𝐚𝐬𝐞 𝐜𝐨𝐧𝐭𝐚𝐜𝐭: – https://www.astuteanalytica.com/industry-report/cardiovascular-devices-market
Top Companies in the Cardiovascular Devices Market
- Abbott
- BIOTRONIK SE & Co. KG
- Boston Scientific Corporation
- Canon Medical Systems
- B. Braun SE
- Cardinal Health
- Medtronic
- LivaNova PLC
- Siemens Healthcare GmbH
- Edwards Lifesciences Corporation
- GE Healthcare
- W. L. Gore & Associates, Inc.
- Other Prominent Players
Market Segmentation Overview
By Device Type
- Diagnostic & Monitoring
- ECG
- Holter Monitors
- Event Monitors
- Implantable Loop Recorders
- Echocardiogram
- Pet Scan
- MRI
- Cardiac CT
- Doppler Fetal Monitors
- Therapeutic & Surgical Devices
- Pacemakers
- Stents
- Catheters and accessories
- Guidewires
- Cannulae
- Electrosurgical Procedures
- Valves
- Occlusion Devices
- Others
By Application
- Cardiac Arrhythmia
- Coronary Artery Disease
- Heart Failure
- Others
By End User
- Hospitals
- Specialty Clinics
- Others
By Region
- North America
- The US
- Canada
- Mexico
- Europe
- Western Europe
- The UK
- Germany
- France
- Italy
- Spain
- Rest of Western Europe
- Eastern Europe
- Poland
- Russia
- Rest of Eastern Europe
- Asia Pacific
- China
- India
- Japan
- Australia and New Zealand
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- South Africa
- UAE
- Rest of MEA
- South America
- Argentina
- Brazil
- Rest of South America
Future Outlook
The outlook for the cardiovascular devices market remains highly positive as innovation continues to reshape cardiovascular care. Electrophysiology, structural heart interventions, AI-powered diagnostics, and remote monitoring technologies are expected to remain primary growth engines throughout the forecast period.
While reimbursement frameworks and healthcare workflow integration remain important challenges, continued investment in minimally invasive therapies, digital healthcare platforms, and precision cardiovascular medicine is expected to support sustained market expansion. Companies capable of combining clinical innovation, AI integration, and global commercialization strategies are likely to strengthen their leadership positions over the next decade.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐑𝐞𝐩𝐨𝐫𝐭@- https://www.astuteanalytica.com/request-sample/cardiovascular-devices-market
𝐀𝐛𝐨𝐮𝐭 𝐀𝐬𝐭𝐮𝐭𝐞 𝐀𝐧𝐚𝐥𝐲𝐭𝐢𝐜𝐚:
Astute Analytica is a global analytics and advisory company that has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in-depth, and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the globe.
They are able to make well-calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyse for them the complex business environment, segment-wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron-come at the top. You can be sure of the best cost-effective, value-added package from us, should you decide to engage with us.
Get in touch with us
Phone number: +18884296757
Email: [email protected]
Visit our website: https://www.astuteanalytica.com/
html,
body,
body:not(.web_whatsapp_com) *,
html body:not(.web_whatsapp_com) *,
html body.ds *,
html body:not(.web_whatsapp_com) div *,
html body:not(.web_whatsapp_com) span *,
html body p *,
html body h1 *,
html body h2 *,
html body h3 *,
html body h4 *,
html body h5 *,
html
body:not(.web_whatsapp_com)
*:not(input):not(textarea):not([contenteditable=””]):not(
[contenteditable=”true”]
),
html
body:not(.web_whatsapp_com)
*[class]:not(input):not(textarea):not([contenteditable=””]):not(
[contenteditable=”true”]
),
html
body:not(.web_whatsapp_com)
*[id]:not(input):not(textarea):not([contenteditable=””]):not(
[contenteditable=”true”]
) {
user-select: text !important;
}
html body *:not(input):not(textarea)::selection,
body *:not(input):not(textarea)::selection,
html body div *:not(input):not(textarea)::selection,
html body span *:not(input):not(textarea)::selection,
html body p *:not(input):not(textarea)::selection,
html body h1 *:not(input):not(textarea)::selection,
html body h2 *:not(input):not(textarea)::selection,
html body h3 *:not(input):not(textarea)::selection,
html body h4 *:not(input):not(textarea)::selection,
html body h5 *:not(input):not(textarea)::selection {
background-color: #3297fd !important;
color: #ffffff !important;
}
/* linkedin */
/* squize */
.www_linkedin_com
.sa-assessment-flow__card.sa-assessment-quiz
.sa-assessment-quiz__scroll-content
.sa-assessment-quiz__response
.sa-question-multichoice__item.sa-question-basic-multichoice__item
.sa-question-multichoice__input.sa-question-basic-multichoice__input.ember-checkbox.ember-view {
width: 40px;
}
/*linkedin*/
/*instagram*/
/*wall*/
.www_instagram_com ._aagw {
display: none;
}
/*developer.box.com*/
.bp-doc .pdfViewer .page:not(.bp-is-invisible):before {
}
/*telegram*/
.web_telegram_org .emoji-animation-container {
display: none;
}
html
body.web_telegram_org
.bubbles-group
> .bubbles-group-avatar-container:not(input):not(textarea):not(
[contenteditable=””]
):not([contenteditable=”true”]),
html
body.web_telegram_org
.custom-emoji-renderer:not(input):not(textarea):not([contenteditable=””]):not(
[contenteditable=”true”]
) {
pointer-events: none !important;
}
/*ladno_ru*/
.ladno_ru [style*=”position: absolute; left: 0; right: 0; top: 0; bottom: 0;”] {
display: none !important;
}
/*mycomfyshoes.fr */
.mycomfyshoes_fr #fader.fade-out {
display: none !important;
}
/*www_mindmeister_com*/
.www_mindmeister_com .kr-view {
z-index: -1 !important;
}
/*www_newvision_co_ug*/
.www_newvision_co_ug .v-snack:not(.v-snack–absolute) {
z-index: -1 !important;
}
/*derstarih_com*/
.derstarih_com .bs-sks {
z-index: -1;
}
html
body
.alc_unlock-pseudo-before.alc_unlock-pseudo-before.alc_unlock-pseudo-before::before {
pointer-events: none !important;
}
html
body
.alc_unlock-pseudo-after.alc_unlock-pseudo-after.alc_unlock-pseudo-after::after {
pointer-events: none !important;
}